BFA
ONC

BlackRock Fund Advisors’s BeOne Medicines Ltd ONC Stock Holding History

BlackRock Fund Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.4M Buy
+144,870
New +$4.55M ﹤0.01% 2987

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

BlackRock Fund Advisors's ONC Position: Q4 2016 in Review

BlackRock Fund Advisors opened a new position in BeOne Medicines Ltd (ONC) in Q4 2016: 144,870 shares worth $4.4M. The stake represents ﹤0.01% of the portfolio and ranks #2987 among its holdings.

54 funds tracked by Wall St. Rank hold ONC as of Q4 2016.

  • BlackRock Fund Advisors held 144,870 shares of BeOne Medicines Ltd worth $4.4M as of Q4 2016.
  • BeOne Medicines Ltd was a new BlackRock Fund Advisors position in Q4 2016.
  • BeOne Medicines Ltd made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2987 holding.
  • 54 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.